//
AIM2-driven inflammasome activation in heart failure
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure
Heart Failure With Preserved Ejection Fraction in the Young
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association